Retatrutide

Retatrutide is a synthetic peptide under investigation as a multi-receptor agonist, commonly described as
engaging GLP-1, GIP, and glucagon receptor pathways. Its structure is designed to combine incretin-like
signalling with additional metabolic pathway engagement, making it a prominent tool compound in modern
metabolic research.

Mechanistic discussion typically centres on receptor-mediated signalling that influences glucose-dependent
insulin secretion, gastric motility signals, appetite regulation circuits, and energy expenditure pathways.
Preclinical and clinical research evaluates endocrine biomarkers, metabolic outputs, and tolerability profiles to
characterise how combined receptor agonism shapes systemic metabolic signalling.

‍